nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Dacarbazine—pancreatic cancer	0.802	1	CiPCiCtD
Melphalan—SLC22A3—Irinotecan—pancreatic cancer	0.104	1	CbGbCtD
Melphalan—Ibuprofen—CXCL8—pancreatic cancer	0.00043	0.504	CrCbGaD
Melphalan—Ibuprofen—PPARG—pancreatic cancer	0.000297	0.348	CrCbGaD
Melphalan—Ibuprofen—PTGS2—pancreatic cancer	0.000125	0.147	CrCbGaD
Melphalan—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000112	0.00119	CcSEcCtD
Melphalan—Stomatitis—Docetaxel—pancreatic cancer	0.000112	0.00119	CcSEcCtD
Melphalan—Jaundice—Docetaxel—pancreatic cancer	0.000112	0.00119	CcSEcCtD
Melphalan—Decreased appetite—Sunitinib—pancreatic cancer	0.000111	0.00119	CcSEcCtD
Melphalan—Leukopenia—Fluorouracil—pancreatic cancer	0.000111	0.00118	CcSEcCtD
Melphalan—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000111	0.00118	CcSEcCtD
Melphalan—Fatigue—Sunitinib—pancreatic cancer	0.000111	0.00118	CcSEcCtD
Melphalan—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00011	0.00117	CcSEcCtD
Melphalan—Cough—Gemcitabine—pancreatic cancer	0.00011	0.00117	CcSEcCtD
Melphalan—Pain—Sunitinib—pancreatic cancer	0.00011	0.00117	CcSEcCtD
Melphalan—Renal failure acute—Epirubicin—pancreatic cancer	0.000109	0.00115	CcSEcCtD
Melphalan—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000108	0.00115	CcSEcCtD
Melphalan—Asthenia—Tamoxifen—pancreatic cancer	0.000107	0.00114	CcSEcCtD
Melphalan—Convulsion—Fluorouracil—pancreatic cancer	0.000107	0.00114	CcSEcCtD
Melphalan—Chest pain—Gemcitabine—pancreatic cancer	0.000107	0.00114	CcSEcCtD
Melphalan—Myalgia—Gemcitabine—pancreatic cancer	0.000107	0.00114	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000107	0.00113	CcSEcCtD
Melphalan—Asthenia—Erlotinib—pancreatic cancer	0.000106	0.00113	CcSEcCtD
Melphalan—Pruritus—Tamoxifen—pancreatic cancer	0.000106	0.00113	CcSEcCtD
Melphalan—Oedema—Irinotecan—pancreatic cancer	0.000106	0.00112	CcSEcCtD
Melphalan—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000106	0.00112	CcSEcCtD
Melphalan—Chest pain—Fluorouracil—pancreatic cancer	0.000106	0.00112	CcSEcCtD
Melphalan—Myalgia—Fluorouracil—pancreatic cancer	0.000106	0.00112	CcSEcCtD
Melphalan—Infection—Irinotecan—pancreatic cancer	0.000105	0.00112	CcSEcCtD
Melphalan—Pruritus—Erlotinib—pancreatic cancer	0.000105	0.00111	CcSEcCtD
Melphalan—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000103	0.0011	CcSEcCtD
Melphalan—Haemoglobin—Docetaxel—pancreatic cancer	0.000103	0.0011	CcSEcCtD
Melphalan—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000103	0.00109	CcSEcCtD
Melphalan—Oedema—Gemcitabine—pancreatic cancer	0.000103	0.00109	CcSEcCtD
Melphalan—Haemorrhage—Docetaxel—pancreatic cancer	0.000103	0.00109	CcSEcCtD
Melphalan—Hepatitis—Docetaxel—pancreatic cancer	0.000103	0.00109	CcSEcCtD
Melphalan—Diarrhoea—Tamoxifen—pancreatic cancer	0.000102	0.00109	CcSEcCtD
Melphalan—Infection—Gemcitabine—pancreatic cancer	0.000102	0.00109	CcSEcCtD
Melphalan—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000102	0.00108	CcSEcCtD
Melphalan—Diarrhoea—Erlotinib—pancreatic cancer	0.000101	0.00108	CcSEcCtD
Melphalan—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000101	0.00108	CcSEcCtD
Melphalan—Oedema—Fluorouracil—pancreatic cancer	0.000101	0.00108	CcSEcCtD
Melphalan—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Urethral disorder—Docetaxel—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Anorexia—Irinotecan—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Hyponatraemia—Epirubicin—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Infection—Fluorouracil—pancreatic cancer	0.000101	0.00107	CcSEcCtD
Melphalan—Renal failure acute—Doxorubicin—pancreatic cancer	0.0001	0.00107	CcSEcCtD
Melphalan—Skin disorder—Gemcitabine—pancreatic cancer	0.0001	0.00106	CcSEcCtD
Melphalan—Thrombocytopenia—Fluorouracil—pancreatic cancer	9.91e-05	0.00105	CcSEcCtD
Melphalan—Tachycardia—Fluorouracil—pancreatic cancer	9.88e-05	0.00105	CcSEcCtD
Melphalan—Hypotension—Irinotecan—pancreatic cancer	9.87e-05	0.00105	CcSEcCtD
Melphalan—Anorexia—Gemcitabine—pancreatic cancer	9.81e-05	0.00104	CcSEcCtD
Melphalan—Anorexia—Fluorouracil—pancreatic cancer	9.65e-05	0.00103	CcSEcCtD
Melphalan—Hypotension—Gemcitabine—pancreatic cancer	9.62e-05	0.00102	CcSEcCtD
Melphalan—Flushing—Docetaxel—pancreatic cancer	9.54e-05	0.00101	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—pancreatic cancer	9.53e-05	0.00101	CcSEcCtD
Melphalan—Vomiting—Tamoxifen—pancreatic cancer	9.52e-05	0.00101	CcSEcCtD
Melphalan—Paraesthesia—Irinotecan—pancreatic cancer	9.49e-05	0.00101	CcSEcCtD
Melphalan—Hypotension—Fluorouracil—pancreatic cancer	9.46e-05	0.00101	CcSEcCtD
Melphalan—Hypersensitivity—Sunitinib—pancreatic cancer	9.45e-05	0.001	CcSEcCtD
Melphalan—Rash—Tamoxifen—pancreatic cancer	9.44e-05	0.001	CcSEcCtD
Melphalan—Dermatitis—Tamoxifen—pancreatic cancer	9.43e-05	0.001	CcSEcCtD
Melphalan—Vomiting—Erlotinib—pancreatic cancer	9.42e-05	0.001	CcSEcCtD
Melphalan—Dyspnoea—Irinotecan—pancreatic cancer	9.42e-05	0.001	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	9.38e-05	0.000997	CcSEcCtD
Melphalan—Rash—Erlotinib—pancreatic cancer	9.34e-05	0.000993	CcSEcCtD
Melphalan—Dermatitis—Erlotinib—pancreatic cancer	9.33e-05	0.000992	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—pancreatic cancer	9.31e-05	0.00099	CcSEcCtD
Melphalan—Dyspepsia—Irinotecan—pancreatic cancer	9.3e-05	0.000989	CcSEcCtD
Melphalan—Immune system disorder—Docetaxel—pancreatic cancer	9.29e-05	0.000987	CcSEcCtD
Melphalan—Mediastinal disorder—Docetaxel—pancreatic cancer	9.26e-05	0.000985	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—pancreatic cancer	9.25e-05	0.000984	CcSEcCtD
Melphalan—Paraesthesia—Gemcitabine—pancreatic cancer	9.24e-05	0.000983	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	9.22e-05	0.00098	CcSEcCtD
Melphalan—Asthenia—Sunitinib—pancreatic cancer	9.2e-05	0.000978	CcSEcCtD
Melphalan—Decreased appetite—Irinotecan—pancreatic cancer	9.18e-05	0.000976	CcSEcCtD
Melphalan—Arrhythmia—Docetaxel—pancreatic cancer	9.18e-05	0.000976	CcSEcCtD
Melphalan—Dyspnoea—Gemcitabine—pancreatic cancer	9.18e-05	0.000976	CcSEcCtD
Melphalan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	9.12e-05	0.00097	CcSEcCtD
Melphalan—Fatigue—Irinotecan—pancreatic cancer	9.11e-05	0.000968	CcSEcCtD
Melphalan—Paraesthesia—Fluorouracil—pancreatic cancer	9.09e-05	0.000966	CcSEcCtD
Melphalan—Alopecia—Docetaxel—pancreatic cancer	9.08e-05	0.000966	CcSEcCtD
Melphalan—Pruritus—Sunitinib—pancreatic cancer	9.07e-05	0.000965	CcSEcCtD
Melphalan—Pain—Irinotecan—pancreatic cancer	9.03e-05	0.000961	CcSEcCtD
Melphalan—Dyspnoea—Fluorouracil—pancreatic cancer	9.02e-05	0.000959	CcSEcCtD
Melphalan—Decreased appetite—Gemcitabine—pancreatic cancer	8.95e-05	0.000951	CcSEcCtD
Melphalan—Dyspepsia—Fluorouracil—pancreatic cancer	8.91e-05	0.000947	CcSEcCtD
Melphalan—Nausea—Tamoxifen—pancreatic cancer	8.9e-05	0.000946	CcSEcCtD
Melphalan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	8.89e-05	0.000945	CcSEcCtD
Melphalan—Fatigue—Gemcitabine—pancreatic cancer	8.87e-05	0.000943	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—pancreatic cancer	8.82e-05	0.000938	CcSEcCtD
Melphalan—Pain—Gemcitabine—pancreatic cancer	8.8e-05	0.000936	CcSEcCtD
Melphalan—Nausea—Erlotinib—pancreatic cancer	8.8e-05	0.000936	CcSEcCtD
Melphalan—Decreased appetite—Fluorouracil—pancreatic cancer	8.8e-05	0.000935	CcSEcCtD
Melphalan—Diarrhoea—Sunitinib—pancreatic cancer	8.78e-05	0.000933	CcSEcCtD
Melphalan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	8.74e-05	0.000929	CcSEcCtD
Melphalan—Pain—Fluorouracil—pancreatic cancer	8.65e-05	0.00092	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—pancreatic cancer	8.56e-05	0.00091	CcSEcCtD
Melphalan—Anaemia—Docetaxel—pancreatic cancer	8.27e-05	0.000879	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—pancreatic cancer	8.23e-05	0.000875	CcSEcCtD
Melphalan—Vomiting—Sunitinib—pancreatic cancer	8.16e-05	0.000867	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—pancreatic cancer	8.1e-05	0.000861	CcSEcCtD
Melphalan—Rash—Sunitinib—pancreatic cancer	8.09e-05	0.00086	CcSEcCtD
Melphalan—Dermatitis—Sunitinib—pancreatic cancer	8.08e-05	0.000859	CcSEcCtD
Melphalan—Urticaria—Fluorouracil—pancreatic cancer	8.04e-05	0.000855	CcSEcCtD
Melphalan—Leukopenia—Docetaxel—pancreatic cancer	8.01e-05	0.000852	CcSEcCtD
Melphalan—Cough—Docetaxel—pancreatic cancer	7.81e-05	0.00083	CcSEcCtD
Melphalan—Hypersensitivity—Irinotecan—pancreatic cancer	7.78e-05	0.000828	CcSEcCtD
Melphalan—Convulsion—Docetaxel—pancreatic cancer	7.75e-05	0.000824	CcSEcCtD
Melphalan—Chest pain—Docetaxel—pancreatic cancer	7.62e-05	0.00081	CcSEcCtD
Melphalan—Myalgia—Docetaxel—pancreatic cancer	7.62e-05	0.00081	CcSEcCtD
Melphalan—Nausea—Sunitinib—pancreatic cancer	7.62e-05	0.00081	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—pancreatic cancer	7.61e-05	0.000809	CcSEcCtD
Melphalan—Asthenia—Irinotecan—pancreatic cancer	7.58e-05	0.000806	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—pancreatic cancer	7.57e-05	0.000805	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	7.57e-05	0.000804	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—pancreatic cancer	7.53e-05	0.0008	CcSEcCtD
Melphalan—Jaundice—Epirubicin—pancreatic cancer	7.53e-05	0.0008	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—pancreatic cancer	7.5e-05	0.000797	CcSEcCtD
Melphalan—Hypersensitivity—Fluorouracil—pancreatic cancer	7.46e-05	0.000793	CcSEcCtD
Melphalan—Asthenia—Gemcitabine—pancreatic cancer	7.38e-05	0.000785	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.3e-05	0.000777	CcSEcCtD
Melphalan—Oedema—Docetaxel—pancreatic cancer	7.3e-05	0.000776	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—pancreatic cancer	7.3e-05	0.000776	CcSEcCtD
Melphalan—Pruritus—Gemcitabine—pancreatic cancer	7.28e-05	0.000774	CcSEcCtD
Melphalan—Infection—Docetaxel—pancreatic cancer	7.26e-05	0.000771	CcSEcCtD
Melphalan—Diarrhoea—Irinotecan—pancreatic cancer	7.23e-05	0.000769	CcSEcCtD
Melphalan—Pruritus—Fluorouracil—pancreatic cancer	7.16e-05	0.000761	CcSEcCtD
Melphalan—Thrombocytopenia—Docetaxel—pancreatic cancer	7.15e-05	0.00076	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—pancreatic cancer	7.13e-05	0.000758	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—pancreatic cancer	7.09e-05	0.000754	CcSEcCtD
Melphalan—Diarrhoea—Gemcitabine—pancreatic cancer	7.04e-05	0.000749	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.01e-05	0.000745	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—pancreatic cancer	6.97e-05	0.000741	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—pancreatic cancer	6.97e-05	0.000741	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—pancreatic cancer	6.97e-05	0.000741	CcSEcCtD
Melphalan—Anorexia—Docetaxel—pancreatic cancer	6.96e-05	0.00074	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—pancreatic cancer	6.93e-05	0.000737	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—pancreatic cancer	6.93e-05	0.000737	CcSEcCtD
Melphalan—Diarrhoea—Fluorouracil—pancreatic cancer	6.92e-05	0.000736	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—pancreatic cancer	6.85e-05	0.000728	CcSEcCtD
Melphalan—Hypotension—Docetaxel—pancreatic cancer	6.82e-05	0.000726	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—pancreatic cancer	6.81e-05	0.000724	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—pancreatic cancer	6.8e-05	0.000723	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—pancreatic cancer	6.76e-05	0.000719	CcSEcCtD
Melphalan—Vomiting—Irinotecan—pancreatic cancer	6.72e-05	0.000714	CcSEcCtD
Melphalan—Rash—Irinotecan—pancreatic cancer	6.66e-05	0.000708	CcSEcCtD
Melphalan—Dermatitis—Irinotecan—pancreatic cancer	6.66e-05	0.000708	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.65e-05	0.000707	CcSEcCtD
Melphalan—Paraesthesia—Docetaxel—pancreatic cancer	6.56e-05	0.000697	CcSEcCtD
Melphalan—Vomiting—Gemcitabine—pancreatic cancer	6.54e-05	0.000696	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—pancreatic cancer	6.51e-05	0.000692	CcSEcCtD
Melphalan—Rash—Gemcitabine—pancreatic cancer	6.49e-05	0.00069	CcSEcCtD
Melphalan—Dermatitis—Gemcitabine—pancreatic cancer	6.48e-05	0.000689	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—pancreatic cancer	6.45e-05	0.000686	CcSEcCtD
Melphalan—Flushing—Epirubicin—pancreatic cancer	6.44e-05	0.000684	CcSEcCtD
Melphalan—Vomiting—Fluorouracil—pancreatic cancer	6.43e-05	0.000684	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—pancreatic cancer	6.43e-05	0.000684	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—pancreatic cancer	6.42e-05	0.000682	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—pancreatic cancer	6.42e-05	0.000682	CcSEcCtD
Melphalan—Rash—Fluorouracil—pancreatic cancer	6.38e-05	0.000678	CcSEcCtD
Melphalan—Dermatitis—Fluorouracil—pancreatic cancer	6.37e-05	0.000678	CcSEcCtD
Melphalan—Decreased appetite—Docetaxel—pancreatic cancer	6.35e-05	0.000675	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.34e-05	0.000674	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.31e-05	0.00067	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—pancreatic cancer	6.3e-05	0.00067	CcSEcCtD
Melphalan—Fatigue—Docetaxel—pancreatic cancer	6.3e-05	0.000669	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—pancreatic cancer	6.29e-05	0.000669	CcSEcCtD
Melphalan—Nausea—Irinotecan—pancreatic cancer	6.28e-05	0.000667	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—pancreatic cancer	6.26e-05	0.000666	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—pancreatic cancer	6.25e-05	0.000664	CcSEcCtD
Melphalan—Pain—Docetaxel—pancreatic cancer	6.25e-05	0.000664	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—pancreatic cancer	6.19e-05	0.000659	CcSEcCtD
Melphalan—Alopecia—Epirubicin—pancreatic cancer	6.13e-05	0.000651	CcSEcCtD
Melphalan—Nausea—Gemcitabine—pancreatic cancer	6.11e-05	0.00065	CcSEcCtD
Melphalan—Nausea—Fluorouracil—pancreatic cancer	6.01e-05	0.000639	CcSEcCtD
Melphalan—Flushing—Doxorubicin—pancreatic cancer	5.95e-05	0.000633	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—pancreatic cancer	5.79e-05	0.000616	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.78e-05	0.000615	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—pancreatic cancer	5.73e-05	0.000609	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—pancreatic cancer	5.67e-05	0.000603	CcSEcCtD
Melphalan—Anaemia—Epirubicin—pancreatic cancer	5.58e-05	0.000593	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—pancreatic cancer	5.4e-05	0.000574	CcSEcCtD
Melphalan—Hypersensitivity—Docetaxel—pancreatic cancer	5.38e-05	0.000572	CcSEcCtD
Melphalan—Cough—Epirubicin—pancreatic cancer	5.27e-05	0.00056	CcSEcCtD
Melphalan—Asthenia—Docetaxel—pancreatic cancer	5.24e-05	0.000557	CcSEcCtD
Melphalan—Convulsion—Epirubicin—pancreatic cancer	5.23e-05	0.000556	CcSEcCtD
Melphalan—Pruritus—Docetaxel—pancreatic cancer	5.17e-05	0.000549	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—pancreatic cancer	5.16e-05	0.000549	CcSEcCtD
Melphalan—Myalgia—Epirubicin—pancreatic cancer	5.14e-05	0.000546	CcSEcCtD
Melphalan—Chest pain—Epirubicin—pancreatic cancer	5.14e-05	0.000546	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.1e-05	0.000543	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—pancreatic cancer	5e-05	0.000532	CcSEcCtD
Melphalan—Diarrhoea—Docetaxel—pancreatic cancer	5e-05	0.000531	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—pancreatic cancer	4.93e-05	0.000524	CcSEcCtD
Melphalan—Oedema—Epirubicin—pancreatic cancer	4.93e-05	0.000524	CcSEcCtD
Melphalan—Infection—Epirubicin—pancreatic cancer	4.89e-05	0.00052	CcSEcCtD
Melphalan—Cough—Doxorubicin—pancreatic cancer	4.87e-05	0.000518	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—pancreatic cancer	4.84e-05	0.000514	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—pancreatic cancer	4.82e-05	0.000513	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—pancreatic cancer	4.81e-05	0.000511	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—pancreatic cancer	4.78e-05	0.000509	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—pancreatic cancer	4.75e-05	0.000506	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—pancreatic cancer	4.75e-05	0.000506	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	4.72e-05	0.000502	CcSEcCtD
Melphalan—Anorexia—Epirubicin—pancreatic cancer	4.7e-05	0.000499	CcSEcCtD
Melphalan—Vomiting—Docetaxel—pancreatic cancer	4.64e-05	0.000494	CcSEcCtD
Melphalan—Rash—Docetaxel—pancreatic cancer	4.6e-05	0.00049	CcSEcCtD
Melphalan—Hypotension—Epirubicin—pancreatic cancer	4.6e-05	0.000489	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—pancreatic cancer	4.6e-05	0.000489	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.56e-05	0.000485	CcSEcCtD
Melphalan—Oedema—Doxorubicin—pancreatic cancer	4.56e-05	0.000485	CcSEcCtD
Melphalan—Infection—Doxorubicin—pancreatic cancer	4.53e-05	0.000481	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.49e-05	0.000477	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.46e-05	0.000474	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—pancreatic cancer	4.45e-05	0.000473	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—pancreatic cancer	4.43e-05	0.000471	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—pancreatic cancer	4.42e-05	0.00047	CcSEcCtD
Melphalan—Dyspnoea—Epirubicin—pancreatic cancer	4.39e-05	0.000467	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—pancreatic cancer	4.34e-05	0.000462	CcSEcCtD
Melphalan—Nausea—Docetaxel—pancreatic cancer	4.34e-05	0.000461	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—pancreatic cancer	4.34e-05	0.000461	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—pancreatic cancer	4.28e-05	0.000455	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—pancreatic cancer	4.26e-05	0.000453	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.25e-05	0.000452	CcSEcCtD
Melphalan—Fatigue—Epirubicin—pancreatic cancer	4.25e-05	0.000452	CcSEcCtD
Melphalan—Pain—Epirubicin—pancreatic cancer	4.21e-05	0.000448	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.15e-05	0.000442	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—pancreatic cancer	4.09e-05	0.000435	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—pancreatic cancer	4.06e-05	0.000432	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—pancreatic cancer	4.01e-05	0.000427	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—pancreatic cancer	3.96e-05	0.000421	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.94e-05	0.000418	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—pancreatic cancer	3.93e-05	0.000418	CcSEcCtD
Melphalan—Urticaria—Epirubicin—pancreatic cancer	3.91e-05	0.000416	CcSEcCtD
Melphalan—Pain—Doxorubicin—pancreatic cancer	3.9e-05	0.000414	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—pancreatic cancer	3.63e-05	0.000386	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—pancreatic cancer	3.62e-05	0.000385	CcSEcCtD
Melphalan—Asthenia—Epirubicin—pancreatic cancer	3.53e-05	0.000376	CcSEcCtD
Melphalan—Pruritus—Epirubicin—pancreatic cancer	3.49e-05	0.000371	CcSEcCtD
Melphalan—Diarrhoea—Epirubicin—pancreatic cancer	3.37e-05	0.000358	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—pancreatic cancer	3.36e-05	0.000357	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—pancreatic cancer	3.27e-05	0.000348	CcSEcCtD
Melphalan—Pruritus—Doxorubicin—pancreatic cancer	3.22e-05	0.000343	CcSEcCtD
Melphalan—Vomiting—Epirubicin—pancreatic cancer	3.13e-05	0.000333	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—pancreatic cancer	3.12e-05	0.000332	CcSEcCtD
Melphalan—Rash—Epirubicin—pancreatic cancer	3.11e-05	0.00033	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—pancreatic cancer	3.1e-05	0.00033	CcSEcCtD
Melphalan—Nausea—Epirubicin—pancreatic cancer	2.93e-05	0.000311	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—pancreatic cancer	2.9e-05	0.000308	CcSEcCtD
Melphalan—Rash—Doxorubicin—pancreatic cancer	2.87e-05	0.000306	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—pancreatic cancer	2.87e-05	0.000305	CcSEcCtD
Melphalan—Nausea—Doxorubicin—pancreatic cancer	2.71e-05	0.000288	CcSEcCtD
